Related Content
Search Google Scholar for:
|
|
Science 14 April 1972: Vol. 176. no. 4031, pp. 170 - 171 DOI: 10.1126/science.176.4031.170
|
|
Articles
The Immune Reaction as a Stimulator of Tumor Growth
Richmond T. Prehn 1
1 Institute for Cancer Research, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111
Various numbers of spleen cells from specifically immunized mice were mixed with constant numbers of target tumor cells, and were inoculated subcutaneously into thymectomized, x-irradiated recipients. Small numbers of admixed immune spleen cells produced a statistically significant, and reproducible, acceleration of tumor growth in the inoculum as compared with controls of either nonimmune spleen cells or spleen cells from animals immune to a different, non-cross-reacting, tumor. Larger. numbers of specifically immune spleen cells, however, produced inhibition of tumor growth. These data imply that the normal immune reaction may have a dual function in relation to neoplasia: (i) stimulation of tumor growth, early in the course of the disease, or whenever the immune reaction is minimal; (ii) inhibition of tumor growth at other times.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.
- M. Hedlund, V. Padler-Karavani, N. M. Varki, and A. Varki (2008)
PNAS
105, 18936-18941
| Abstract »
| Full Text »
| PDF »
- A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans.
- F. I. Staquicini, A. Tandle, S. K. Libutti, J. Sun, M. Zigler, M. Bar-Eli, F. Aliperti, E. C. Perez, J. E. Gershenwald, M. Mariano, et al. (2008)
Cancer Res.
68, 8419-8428
| Abstract »
| Full Text »
| PDF »
- Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.
- S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi (2007)
PNAS
104, 6770-6775
| Abstract »
| Full Text »
| PDF »
- Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines.
- E. Gitelson, C. Hammond, J. Mena, M. Lorenzo, R. Buckstein, N. L. Berinstein, K. Imrie, and D. E. Spaner (2003)
Clin. Cancer Res.
9, 1656-1665
| Abstract »
| Full Text »
| PDF »
- Variability of Placental Expression of Cyclin E Low Molecular Weight Variants.
- A. Bukovsky, M. Cekanova, M. R. Caudle, J. Wimalasena, J. S. Foster, J. A. Keenan, and R. F. Elder (2002)
Biol Reprod
67, 568-574
| Abstract »
| Full Text »
| PDF »
- Enhanced Growth of Primary Tumors in Cancer-prone Mice after Immunization against the Mutant Region of an Inherited Oncoprotein.
- C. T. Siegel, K. Schreiber, S. C. Meredith, G. B. Beck-Engeser, D. W. Lancki, C. A. Lazarski, Y.-X. Fu, D. A. Rowley, and H. Schreiber (1999)
J. Exp. Med.
191, 1945-1956
| Abstract »
| Full Text »
| PDF »
- The Flip Side of Tumor Immunity.
- R. T. Prehn and L. M. Prehn (1989)
Arch Surg
124, 102-106
| Abstract »
| PDF »
- Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogen.
- L. Prehn and E. Lawler (1979)
Science
204, 309-310
| Abstract »
| PDF »
- Multiplicity of the Tumor-Directed Immune Response: Implications for Immunotherapy.
- W. R. Beltz and N. L. Levy (1975)
Arch Otolaryngol Head Neck Surg
101, 660-663
| Abstract »
| PDF »
- Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice.
- O. Stutman (1974)
Science
183, 534-536
| Abstract »
| PDF »
- Stimulation of Cells by Antibody.
- W. T. Shearer, G. W. Philpott, and C. W. Parker (1973)
Science
182, 1357-1359
| Abstract »
| PDF »
|
|